Stay updated on Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision from v3.3.1 to v3.3.2 appears to be a minor update to page formatting or documentation; no changes to study content, eligibility criteria, endpoints, or locations were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:33:10.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.2.0 to v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T11:24:06.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A government funding/status notice has been removed from the study page; core trial information, eligibility criteria, and contact details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:13:56.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    No substantive changes detected to core study content. The information presented remains the same, including objectives, eligibility criteria, and outcomes.
    Difference
    0.3%
    Check dated 2025-11-03T00:48:17.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and the addition of an operating-status notice; the previous v3.1.0 reference was removed.
    Difference
    3%
    Check dated 2025-10-05T07:30:37.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Update includes a new version tag (v3.1.0) and removal of the Plasma cell myeloma resource from the Genetic and Rare Diseases Information Center section; indicates content reorganization with versioning rather than adding substantive new materials.
    Difference
    0.4%
    Check dated 2025-09-28T02:56:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.